WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Schedules Third-Quarter 2026 Earnings

Investors interested in Medical Services stocks are likely familiar with Progyny (PGNY) and Charles

CRL shares have surged 75.8% in a year as RMS trends improve, AI-enabled testing expands and cash fl

Partnership reinforces continued investment in digitization, automation, and client-facing transpare

WILMINGTON, Mass. & LONDON--(BUSINESS WIRE)---- $CRL #DrugDiscover--Charles River Laboratories Inter

Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 3.32% on an annualize

Shares of Charles River Laboratories International, Inc. (NYSE: CRL - Get Free Report) have been ass

Jefferies analyst David Windley maintains Charles River (NYSE:CRL) with a Buy and raises the pric

Charles River Laboratories International NYSE: CRL outlined a strategy to accelerate growth, expand

Deutsche Bank analyst Justin Bowers maintains Charles River (NYSE:CRL) with a Buy and raises the

TD Cowen analyst Charles Rhyee maintains Charles River (NYSE:CRL) with a Buy and raises the price

Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and ra

RBC Capital analyst Ryan Halsted maintains Charles River (NYSE:CRL) with a Outperform and raises

Barclays analyst Luke Sergott maintains Charles River (NYSE:CRL) with a Overweight and raises the

Mizuho analyst Ann Hynes maintains Charles River (NYSE:CRL) with a Neutral and raises the price t

Baird analyst Eric Coldwell maintains Charles River (NYSE:CRL) with a Outperform and raises the p

Charles River Laboratories International, Inc. (CRL) Analyst/Investor Day Transcript

Stocks pared a sharp morning selloff after sources said US and Iranian negotiators are discussing a

Nasdaq fell 150+ points, while Everpure jumped 14% after unveiling growth plans and a FY2028 outlook

Charles River Laboratories International, Inc. (NYSE: CRL) will host its 2026 Investor Day today, Se

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Highlights Refreshed Strategic Vision to Drive Pro

Adaptive Biotechnologies (NASDAQ: ADPT - Get Free Report) and Charles River Laboratories Internation

Investors looking for stocks in the Medical Services sector might want to consider either Progyny (P

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (N

Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.57% on an annualize

Charles River Laboratories International, Inc. (CRL) Presents at 2026 Global Healthcare Conference T

Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 24th Annual Global H

Evercore ISI Group analyst Ross Muken maintains Charles River (NYSE:CRL) with a Outperform and ra

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at t

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Morgan Stanley and Bair

Amundi trimmed its position in Charles River Laboratories International, Inc. (NYSE: CRL) by 46.7% d

IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight he

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River Laboratories International, Inc. (N

Charles River (CRL) reported earnings 30 days ago. What's next for the stock?

Charles River's improving DSA demand and strategic investments support growth, but uneven recovery a

Wall Street analysts upgraded AVITA, Etsy, Unity, and raised target prices for these stocks. See wha

Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and i

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies re

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet

Wall Street analysts change outlook on top names. Complete view of analyst rating changes including

Top Wall Street analysts upgraded MITT & MFA. See ratings & price targets for these stocks.

Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J

Charles River to sell CDMO, Cell Solutions, and European assets, raise 2026 earnings outlook as shar

Charles River Laboratories International, Inc. (NYSE:CRL) today announced that it has signed definit